Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.

Détails

Ressource 1Télécharger: 29920932.pdf (757.55 [Ko])
Etat: Public
Version: Author's accepted manuscript
Licence: Non spécifiée
ID Serval
serval:BIB_6D920C4CDD77
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
Périodique
American journal of transplantation
Auteur(s)
Quteineh L., Wójtowicz A., Bochud P.Y., Crettol S., Vandenberghe F., Venetz J.P., Manuel O., Golshayan D., Lehmann R., Mueller N.J., Binet I., van Delden C., Steiger J., Mohacsi P., Dufour J.F., Soccal P.M., Kutalik Z., Marques-Vidal P., Vollenweider P., Recher M., Hess C., Pascual M., Eap C.B.
Collaborateur(s)
Swiss Transplant Cohort Study
ISSN
1600-6143 (Electronic)
ISSN-L
1600-6135
Statut éditorial
Publié
Date de publication
01/2019
Peer-reviewed
Oui
Volume
19
Numéro
1
Pages
238-246
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
New-onset diabetes mellitus after transplantation (NODAT) is a complication following solid organ transplantation (SOT) and may be related to immune or inflammatory responses. We investigated whether single nucleotide polymorphisms (SNPs) within 158 immune- or inflammation-related genes contribute to NODAT in SOT recipients. The association between 263 SNPs and NODAT was investigated in a discovery sample of SOT recipients from the Swiss Transplant Cohort Study (STCS, n <sub>1</sub> = 696). Positive results were tested in a first STCS replication sample (n <sub>2</sub> = 489) and SNPs remaining significant after multiple test corrections were tested in a second SOT replication sample (n <sub>3</sub> = 156). Associations with diabetic traits were further tested in several large general population-based samples (n > 480 000). Only SP110 rs2114592C>T remained associated with NODAT in the STCS replication sample. Carriers of rs2114592-TT had 9.9 times (95% confidence interval [CI]: 3.22-30.5, P = .00006) higher risk for NODAT in the combined STCS samples (n = 1184). rs2114592C>T was further associated with NODAT in the second SOT sample (odds ratio: 4.8, 95% CI: 1.55-14.6, P = .006). On the other hand, SP110 rs2114592C>T was not associated with diabetic traits in population-based samples, suggesting a specific gene-environment interaction, possibly due to the use of specific medications (ie, immunosuppressants) in transplant patients and/or to the illness that may unmask the gene effect.
Mots-clé
clinical research/practice, diabetes, genetics, new onset/posttransplant
Pubmed
Web of science
Création de la notice
28/06/2018 8:50
Dernière modification de la notice
04/12/2019 6:31
Données d'usage